GEMCITABINE, DEXAMETHASONE, AND CISPLATIN (GDP): EFFECTIVE AND WELL-TOLERATED SALVAGE THERAPY FOR RELAPSED/REFRACTORY HODGKIN LYMPHOMA (HL)

被引：0
|
作者：
Moccia, A. A. [1 ,2 ]
Hoskins, P. [1 ,2 ]
Klasa, R. [1 ,2 ]
Savage, K. J. [1 ,2 ]
Shenkier, T. [1 ,2 ]
Skinnider, B. [2 ,3 ]
Slack, G. [2 ,3 ]
Gascoyne, R. D. [2 ,3 ]
Connors, J. M. [1 ,2 ]
Sehn, L. H. [1 ,2 ]
机构：
[1] British Columbia Canc Agcy, Dept Med Oncol, Vancouver, BC, Canada
[2] Univ British Columbia, Vancouver, BC, Canada
[3] British Columbia Canc Agcy, Dept Pathol, Vancouver, BC, Canada
来源：
HAEMATOLOGICA | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P097
引用
收藏
页码：S28 / S29
页数：2
相关论文
共 50 条
  • [21] Efficacy of Gemcitabine as Salvage Therapy for Relapsed and Refractory Aggressive Non-Hodgkin Lymphoma
    Zlotnick, Maya
    Avigdor, Abraham
    Ribakovsky, Elena
    Nagler, Arnon
    Kedmi, Meirav
    [J]. ACTA HAEMATOLOGICA, 2019, 141 (02) : 84 - 90
  • [22] Gemcitabine, Cisplatin, and Dexamethasone as a Salvage and Mobilization Chemotherapy Before Autologous Stem Cell Transplantation is Effective and Safe Outpatient Regimen in Relapsed and Refractory Hodgkin Lymphoma Patients
    Gokmen, Ayla
    Sahin, Ugur
    Soydan, Ender
    Gokgoz, Zafer
    Okcu, Mevlude Kurdal
    Ozan, Ulku
    Arslan, Onder
    Ilhan, Osman
    Ozcan, Muhit
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (10): : E885 - E892
  • [23] Vinorelbine, Paclitaxel, Etoposide, Cisplatin, and Cytarabine (VTEPA) Is an Effective Second Salvage Therapy for Relapsed/Refractory Hodgkin Lymphoma
    Sinha, Rajni
    Shenoy, Pareen J.
    King, Nassoma
    Lechowicz, Mary Jo
    Bumpers, Kevin
    Hutcherson, Donald
    Arellano, Martha
    Langston, Amelia
    Kaufman, Jonathan
    Heffner, Leonard T., Jr.
    Waller, Edmund K.
    Nooka, Ajay
    Flowers, Christopher R.
    Lonial, Sagar
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (06): : 657 - 663
  • [24] Gemcitabine, carboplatin, and dexamethasone as salvage chemotherapy for outpatients with relapsed or refractory lymphoma
    Iino, Masaki
    Yamamoto, Takeo
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [25] Gemcitabine, vinorelbine and dexamethasone: A safe and effective regimen for treatment of relapsed/refractory hodgkin's lymphoma
    Ganesan, Prasanth
    Mehra, Nikita
    Joel, Anjana
    Radhakrishnan, Venkatraman
    Dhanushkodi, Manikandan
    Kalayarasi, Jayachandran Perumal
    Kannan, Krishnarathinam
    Ganesan, Trivadi S.
    Sagar, Tenali Gnana
    [J]. LEUKEMIA RESEARCH, 2019, 84
  • [26] Gemcitabine, Dexamethasone, Cisplatin plus /- Rituximab (GDP plus /- R) Is Highly Effective As a Mobilization Regimen in Relapsed or Refractory Lymphoma (COLLYM STUDY)
    Adam, Jean-Philippe
    Taillefer, Vincent T.
    Emond, Marianne
    Leblanc, Marie-Helene
    Besner-Morin, Olivier
    Doucet, Stephane
    [J]. BLOOD, 2018, 132
  • [27] Gemcitabine, cisplatin and dexamethasone as a salvage and mobilization chemotheraphy before autologous stem-cell transplantation is effective and safe outpatient regimen in relapsed/refractory hodgkin lymphoma patients
    Gokmen, A.
    Sahin, U.
    Soydan, E.
    Kurdal, M.
    Ozan, U.
    Ilhan, O.
    Arslan, O.
    Ozcan, M.
    [J]. BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 305 - 305
  • [28] Gemcitabine, Vinorelbine and Dexamethasone (GVDexa) As Second-Line Salvage Regimen in Relapsed and Refractory Hodgkin's Lymphoma
    Joel, Anjana
    Ganesan, Prasanth
    Sagar, Tenali Gnana
    Kannan, Krishnarathnam
    Ganesan, Trivadi
    Radhakrishnan, Venkatraman
    Rajendranath, Rejiv
    Sundersingh, Shirley
    Vikas, Vandana
    [J]. BLOOD, 2015, 126 (23)
  • [29] Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients
    Ulu, Bahar Uncu
    Dal, Mehmet Sinan
    Hindilerden, Ipek Yonal
    Akay, Olga Meltem
    Mehtap, Ozgur
    Buyukkurt, Nurhilal
    Hindilerden, Fehmi
    Gunes, Ahmet Kursad
    Yigenoglu, Tugce Nur
    Basci, Semih
    Cakar, Merih Kizil
    Acik, Didar Yanardag
    Korkmaz, Serdal
    Ulas, Turgay
    Ozet, Gulsum
    Ferhanoglu, Burhan
    Nalcaci, Meliha
    Altuntas, Fevzi
    [J]. JOURNAL OF CHEMOTHERAPY, 2022, 34 (03) : 190 - 198
  • [30] Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma
    M Ng
    J Waters
    D Cunningham
    I Chau
    A Horwich
    M Hill
    A R Norman
    A Wotherspoon
    D Catovsky
    [J]. British Journal of Cancer, 2005, 92 : 1352 - 1357
12345